Recent News Releases

 

Latest News Releases

Latest News Releases

CSL to Move Global Headquarters
07 Aug 2019 Company

Major landmark development will significantly increase CSL’s presence in the Parkville biomedical precinct and cement Melbourne’s place as a world-class research destination

CSL Renews Partnership with NYSF
15 Mar 2019 Company

MELBOURNE, Australia - CSL today announced its continued partnership with the National Youth Science Forum (NYSF) signing a new three-year agreement in support of programs that encourage life-long STEM literacy.

CSL at J.P. Morgan's 2019 Healthcare Conference
07 Jan 2019 Company

CSL Limited today announced that it will present at the 2019 J.P. Morgan Annual Healthcare Conference. CEO and Managing Director Paul Perreault will present the company’s overview on Wednesday, January 9 at 8:30 a.m. Pacific time.

Nancy Millis building opens at Bio21 Institute
14 Dec 2018 Company

The Honourable John Brumby AO today formally opened the new ‘Nancy Millis’ building, an expansion of the Bio21 Institute of Molecular Science and Biotechnology, University of Melbourne, incorporating CSL’s Global Hub for Research and Translational Medicine.

Developments in cell-based vaccine technology
05 Dec 2018 Innovation

CSL spotlights developments in cell-based vaccine technology at Australian Research and Development briefing

2019 Centenary Fellowship Winners Announced
11 Oct 2018 Company

Two Australian scientists have each been awarded an AUD$1.25 million, five-year, CSL Centenary Fellowship to further research into why so many people die from infection following stroke and how we might develop better vaccines against diseases such as tuberculosis.

Media Contacts

Christina Hickie

CSL Limited
Senior Manager, Communications
Phone: +61 429 609 762

Want to know more about how CSL, and our CSL Behring division are sharing stories of biotech's promise?

Visit Vita
News archive 2016 pdf
News archive 2015 pdf
News archive 2014 pdf
News archive 2013 pdf

Get our latest news in your inbox

mail@example.com
First name
Last name
Country

Thanks!

Thank you for subscribing
to the CSL newsletter